Correction: TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation

Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-019-0293-x, published online 12 September 2019

The authors regret to report errors in the paper published. We identified an error in Figure 3e, where the control image was in duplicate with the control image of Figure 4c. Additionally, the image in Figure 4d was also inappropriately used. Therefore, we kindly request that the images in Figure 4c and 4d be corrected. These images and information are replaced by right ones of the same batch. However, these errors will not affect the correctness of the results of the paper.

Fig. 4: Effect of TSPO knockdown on the proliferation and migration of VSMCs.

A10 cells were transfected with TSPO siRNA or scramble siRNA (vehicle) for 48 h and then exposed to 10 ng/mL PDGF-BB for another 24 h. The cells were harvested for various assays. a The mRNA level of TSPO was assessed by PCR (n = 6). b Cell proliferation was determined by the MTT assay. c, d Cell migration was determined by the transwell and wound-healing assays. Representative images and statistical graphs are presented (n = 10; *P < 0.05 vs. control, ^#P < 0.05 vs. vehicle transfection + PDGF-BB).